The global Blood Based Biomarker Market is estimated to be valued at US$ 18.8 billion in 2022 and is expected to exhibit a CAGR of 12.8% over the forecast period 2023-2030, as highlighted in a new rep
Founded year: | Not set |
Funding rounds: | Not set |
Total funding amount: | Not set |